C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/28/2002	WO2002095075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095065A2 G-protein coupled receptor arrays
11/28/2002	WO2002095062A2 Serine-threonine phosphatase protein of a parasitic organism of the apicomplexa phylum, applications in therapeutics
11/28/2002	WO2002095058A2 Emission ratiometric indicators of phosphorylation
11/28/2002	WO2002095056A2 A novel g protein-coupled receptor, gave1
11/28/2002	WO2002095052A2 Pna probes, probe sets, methods and kits pertaining to the detection of candida
11/28/2002	WO2002095051A2 Mage-a3 peptides presented by hla class ii molecules
11/28/2002	WO2002095049A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/28/2002	WO2002095043A1 Cellular signal-responsive gene transcriptional regulation system
11/28/2002	WO2002095041A1 Virus high effectively expressing the tumor interferon and specifically reproduction in tumor cells and the use thereof
11/28/2002	WO2002095040A1 Delections in arterivirus replicons
11/28/2002	WO2002095036A2 A novel intein and uses thereof
11/28/2002	WO2002095032A2 Methods and compositions of human proteins and uses thereof.
11/28/2002	WO2002095030A2 Modulation of cd200 receptors
11/28/2002	WO2002095029A2 Nucleic acid and protein sequences of bovine epidermal growth factor
11/28/2002	WO2002095028A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria
11/28/2002	WO2002095026A1 Method of proliferating terminal differentiated cells and recombinant vector therefor
11/28/2002	WO2002095021A2 A repressor-mediated regulation system for control of gene expression in plants
11/28/2002	WO2002095020A1 A gene and uses therefor
11/28/2002	WO2002095019A1 Removal of plasmin(ogen) from protein solutions
11/28/2002	WO2002095015A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002095010A2 Human secreted proteins
11/28/2002	WO2002095009A2 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
11/28/2002	WO2002095008A2 Methods of modulating surfactant phospholipid production
11/28/2002	WO2002095004A2 Foamy virus mutant reverse transcriptase
11/28/2002	WO2002095001A2 Btf3: an inhibitor of apoptosis
11/28/2002	WO2002094999A2 Polynucleotide encoding a novel trp channel family member, trp-plik2, and splice variants thereof
11/28/2002	WO2002094996A2 Ccl1 polynucleotides and polypeptides and uses thereof
11/28/2002	WO2002094994A2 Chimeric antigen-specific t cell-activating polypeptides
11/28/2002	WO2002094993A2 Kin28 polynucleotides and polypeptides and uses thereof
11/28/2002	WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002	WO2002094989A2 Retroviral vectors and methods of using same
11/28/2002	WO2002094988A2 Lipid-associated molecules
11/28/2002	WO2002094985A2 Beta-secretase substrates and uses thereof
11/28/2002	WO2002094980A2 Phytocystatin
11/28/2002	WO2002094877A2 New nuclear receptor cofactors and related modulators
11/28/2002	WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	WO2002094875A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION
11/28/2002	WO2002094874A2 Internalisation of virus into cells
11/28/2002	WO2002094873A2 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use
11/28/2002	WO2002094872A1 Therapeutic uses of keratinocyte growth factor-2
11/28/2002	WO2002094871A1 Novel keratinocyte growth factor-2 analogue in hair follicle
11/28/2002	WO2002094870A2 Proteins and nucleic acids encoding same
11/28/2002	WO2002094869A1 Lectin protein prepared from maackia fauriei, process for preparing the same and the use thereof
11/28/2002	WO2002094868A2 Staphylococcus aureus proteins and nucleic acids
11/28/2002	WO2002094867A2 Sequence of the photorhabdus luminescens strain tt01 genome and uses
11/28/2002	WO2002094866A1 Pre-s protein of hepatitis b virus (hbv) as an adjuvant and a component of hbv vaccine
11/28/2002	WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
11/28/2002	WO2002094864A2 Human cdnas and proteins and uses thereof
11/28/2002	WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002	WO2002094862A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002	WO2002094861A2 Genes and proteins involved in the biosynthesis of enediyne ring structures
11/28/2002	WO2002094860A2 Dimerized t-cell receptor fragment, its compositions and use
11/28/2002	WO2002094859A2 Mage-a1 peptides for treating or preventing cancer
11/28/2002	WO2002094858A1 Antiviral compounds derived from the non-glycosylated central subdomain of respiratory syncytial virus (rsv) protein g.
11/28/2002	WO2002094855A2 Peptide synthesis method
11/28/2002	WO2002094852A2 Taci-immunoglobulin fusion proteins
11/28/2002	WO2002094851A2 Peptide vaccines against group a streptococci
11/28/2002	WO2002094850A2 Haplotypes of the gnrh2 gene
11/28/2002	WO2002094775A2 Recombinant simian gpr3 receptor
11/28/2002	WO2002094378A2 Increased functional activity and/or expression of abc transporters protects against the loss of dopamine neurons associated with parkinson's disease
11/28/2002	WO2002094344A2 Method and apparatus for removal of insulin binding proteins (ibp) from biological fluids
11/28/2002	WO2002094318A1 Vector for targeted delivery to cells
11/28/2002	WO2002094314A1 Tsg101 as inhibitor of hiv production
11/28/2002	WO2002094313A2 Vaccine composition
11/28/2002	WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002	WO2002094200A2 Pulmonary administration of chemically modified insulin
11/28/2002	WO2002094198A2 Modulation of cell division by an early mitotic inhibitor protein
11/28/2002	WO2002094177A2 Novel nucleic acids and their therapeutic use in ophthalmology
11/28/2002	WO2002094029A1 Method of inhibiting fungal growth
11/28/2002	WO2002094008A2 Transgenic plants protected against parasitic plants
11/28/2002	WO2002093998A2 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002080858A3 Use of kpv tripeptide for dermatological disorders
11/28/2002	WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002	WO2002077185A3 Methods for modifying flowering phenotypes
11/28/2002	WO2002077019A9 Methods and compositions for modulating tumor suppression
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002068652A9 Nov-x proteins and nucleic acids encoding same
11/28/2002	WO2002068606A3 Methods for the identification of herbicides and the modulation of plant growth
11/28/2002	WO2002067859A3 Ascorbic acid analogs for metalloradiopharmaceuticals
11/28/2002	WO2002066636A3 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/28/2002	WO2002063019A3 Methods for generating resistance against cgmmv in plants
11/28/2002	WO2002057741A3 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
11/28/2002	WO2002056837A9 Inhibition of protein-phosphatases for the treatment of heart failure
11/28/2002	WO2002054065A3 Reversible mhc multimer staining for functional purification of antigen-specific t cells
11/28/2002	WO2002040538A3 Regulation of human nmda receptor
11/28/2002	WO2002036733A3 Cd36 as a heat shock protein receptor and uses thereof
11/28/2002	WO2002034906A3 Method for exposing peptides and polypeptides on the cell surface of bacteria
11/28/2002	WO2002032936A9 E. histolytica-specific antibodies and clinical uses thereof
11/28/2002	WO2002029049A3 Regulation of human sodium-dependent monoamine transporter
11/28/2002	WO2002022665A9 Novel g protein-coupled receptor proteins and dnas tehreof
11/28/2002	WO2002016579A3 Nucleic acids, vectors, host cells, polypeptides and uses thereof
11/28/2002	WO2002008442A9 Means and methods for raising antibody concentration in compartments of the body of a non human animal
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001098360A3 Gp354 nucleic acids and polypeptides
11/28/2002	WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro

1 ... 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 ... 2916